Pomalidomide in Relapsed and Refractory Multiple Myeloma (RRMM)
Clinical trial NCT02406222 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02406222
- Sponsor
- University of Leeds
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2022-12-01
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.